Data Supports Deramiocel’s Sustained Efficacy and Safety in Treating DMD- -Improvements Seen in Multiple Cardiac and Skeletal ...

LONDON and NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicine company, today announced a poster presentation at ...

The purpose of vaccinating children was originally to stop dangerous diseases that spread easily and quickly in a school room ...

IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, off-the-shelf, immune-modulating therapeutic cancer vaccines based on its T-win ® platform, today announced two ...

MNOV READ THE FULL MNOV RESEARCH REPORT On September 30, 2024, MediciNova, Inc. (NASDAQ:MNOV) announced that MN-166 (ibudilast) will be evaluated in an Expanded Access Protocol (EAP) trial to evaluate ...

The focus of this year's World One Health Congress (WOHC), held in Cape Town, South Africa, 20–23 Sep 2024, was on improving ...

New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants Paris, October 9, 2024. Sanofi advances its ambition to protect all infants ...

To provide a platform for groundbreaking discussions on the latest trends in Pharmaco therapeutics and fostering valuable ...

US campuses have played an actively complicit role in the CCP’s efforts to threaten international Chinese students into ...

Mumbai: Sun Pharmaceutical Industries Limited has announced that it will present abstracts across its dermatology portfolio ...

Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...